S100A9 was found in the CRC microenvironment to activate the MDSC immune suppressive program through TLR4-dependent NF-κB signaling pathways, resulting in upregulated Arg1, iNOS, and IL-10 production (55). Here, S100A9 is linked to colorectal carcinoma.